-
My Account
My Account
BSE Live
Mar 05, 16:00Prev. Close
6700.05
Open Price
6748.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 05, 15:58Prev. Close
6699.45
Open Price
6700.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Nine Months Results of Procter & Gamble Health (in Rs. Cr.) | Sep '19 | Sep '18 | Sep '17 | Sep '16 | Sep '15 | |
| Net Sales/Income from operations | 689.83 | 644.60 | 779.04 | 728.33 | 676.34 | |
| Other Operating Income | -- | -- | 20.79 | 16.46 | 25.68 | |
| Total Income From Operations | 689.83 | 644.60 | 799.83 | 744.79 | 702.02 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 224.98 | 182.24 | 185.99 | 182.92 | 193.42 | |
| Purchase of Traded Goods | 17.57 | 22.06 | 129.46 | 127.04 | 138.09 | |
| Increase/Decrease in Stocks | -22.89 | -1.44 | 10.15 | 13.54 | -5.05 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 93.97 | 92.97 | 124.74 | 114.66 | 95.90 | |
| Depreciation | 12.88 | 16.49 | 19.34 | 18.69 | 14.98 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 221.65 | 215.97 | 242.59 | 217.74 | 221.23 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 141.68 | 116.31 | 87.57 | 70.19 | 43.44 | |
| Other Income | 41.89 | 17.21 | 18.57 | 16.11 | 16.45 | |
| P/L Before Int., Excpt. Items & Tax | 183.56 | 133.53 | 106.14 | 86.30 | 59.89 | |
| Interest | -- | -- | -- | -- | -- | |
| P/L Before Exceptional Items & Tax | 183.56 | 133.53 | 106.14 | 86.30 | 59.89 | |
| Exceptional Items | -- | 6.57 | -- | -- | -- | |
| P/L Before Tax | 183.56 | 140.09 | 106.14 | 86.30 | 59.89 | |
| Tax | 63.02 | 51.84 | 39.50 | 28.61 | 20.90 | |
| P/L After Tax from Ordinary Activities | 120.55 | 88.25 | 66.64 | 57.69 | 38.99 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | 35.13 | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 120.55 | 123.38 | 66.64 | 57.69 | 38.99 | |
| Equity Share Capital | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 72.62 | 53.17 | 40.15 | 34.75 | 23.49 | |
| Diluted EPS | 72.62 | 53.17 | 40.15 | 34.75 | 23.49 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 72.62 | 53.17 | 40.15 | 34.75 | 23.49 | |
| Diluted EPS. | 72.62 | 53.17 | 40.15 | 34.75 | 23.49 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | 0.80 | |
| Share Holding (%) | -- | -- | -- | -- | 48.20 | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | 0.86 | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | 100.00 | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | 51.80 |
25.02.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
23.02.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
11.02.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
15.12.2020
Procter&Gamble Standalone September 2020 Net Sales at Rs 263.97 crore, up 17.23% Y-o-Y
